We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advion BioServices Announces Expansion

Advion BioServices Announces Expansion

Advion BioServices Announces Expansion

Advion BioServices Announces Expansion

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Advion BioServices Announces Expansion"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Advion BioServices, Inc. has announced during the 2007 AAPS Annual Meeting and Exposition that it is expanding its capacity with the recent acquisition of two Applied Biosystems/MDS Sciex API 5000 mass spectrometers and Waters Acquity UPLC capability.

In addition, the company has hired 17 employees since relocating to its new laboratory facility in late April of this year.

The Company says that the addition of these API 5000 mass spectrometers brings the number of triple quadrupole mass spectrometers within Advion’s bioanalytical laboratory in Ithaca, New York to 24, making it one of the largest bioanalytical contract laboratories in the world. The acquisition of UPLC by Advion provides a wider range of liquid chromatography capabilities to offer its customers.

“The addition of API 5000 and Acquity UPLC systems provides our scientists with technology to meet the needs of our clients for LC/MS/MS assays with improved sensitivity,” remarked Tom Kurz, Advion BioServices’ president. “Not only does this new equipment improve our capability, but in combination with the recent expansion of our scientific staff provides us with increased capacity to serve our clients.”

Additionally, Advion has recognized a 35% growth in quarterly revenue versus prior year due in part to expanded offerings including dose formulation analysis, sample management and storage, metabolism services, PK data analysis, and immunoassay services.

“The new services were developed and offered as a direct result of client requests that such services be provided by Advion under our high standards for scientific excellence, regulatory compliance, and unparalleled service,” Kurz commented.